Search Browse Earnings

Incannex Healthcare Inc. — SlamSEC

Incannex Healthcare Inc.

Nasdaq:IXHL

Pharmaceutical Preparations·NORWEST NSW

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$12,000

FY 2024

Adj. EBITDA

-$29.9M

-249483.3% margin

FY 2025

Net Income

-$18.5M

-153825.0% margin

FY 2025

EPS (Diluted)

-$1.15

FY 2025

Stock Price

$4.22

+6.0%

2026-03-09

52W Range

$0.08 – $5.17

P/E Ratio

-3.7x

Market Cap

$1.5B

Cash

$5.9M

FY 2025

Total Debt

—

Net Cash

$5.9M

FY 2024

Enterprise Value

$1.5B

Debt / EBITDA

0.2x

FY 2024

EV / EBITDA

-50.3x

Employees

—

CEO

Latham Joel

CFO

Swan Joseph